panitumumab
takeda,amgen
['triplet', 'triplete']
#asco22 | about the #triplete trial "the results highlight that the optimization of the use of targeted agents in clinically and molecularly selected patients, there is no added value from the intensification of the associated chemotherapy. 
Latest research in oncology | Breaking news, insights, interviews, live tweeting and updates from major conferences | Published by @ilpensiero | @think2it